IRIS
BUTTARI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.097
EU - Europa 1.335
AS - Asia 950
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
AF - Africa 2
Totale 15.415
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.081
SG - Singapore 425
IT - Italia 330
KR - Corea 238
IE - Irlanda 235
CN - Cina 185
DE - Germania 157
UA - Ucraina 136
RU - Federazione Russa 104
GB - Regno Unito 89
FR - Francia 68
PL - Polonia 56
SE - Svezia 47
FI - Finlandia 38
HK - Hong Kong 38
BE - Belgio 20
CZ - Repubblica Ceca 18
CA - Canada 13
IN - India 11
JP - Giappone 11
EU - Europa 9
UZ - Uzbekistan 9
BR - Brasile 8
RO - Romania 8
HR - Croazia 5
IR - Iran 5
SA - Arabia Saudita 5
AU - Australia 4
GR - Grecia 4
NL - Olanda 4
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
DM - Dominica 3
IL - Israele 3
MY - Malesia 3
PK - Pakistan 3
TR - Turchia 3
AR - Argentina 2
AT - Austria 2
DK - Danimarca 2
ES - Italia 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 15.415
Salva come PNG Salva come JPEG
Città #
Wilmington 3.556
Houston 3.309
Woodbridge 2.787
Chandler 550
Fairfield 514
Singapore 366
Ann Arbor 288
Ashburn 226
Dublin 204
Seattle 199
Cambridge 173
New York 155
Medford 133
Rome 118
Jacksonville 94
Santa Clara 85
Dearborn 80
Lawrence 64
Kraków 52
Zhengzhou 45
Beijing 41
Munich 29
Palo Alto 25
San Diego 24
London 23
Milan 22
Norwalk 22
Philadelphia 21
Brussels 20
Moscow 20
Southern 19
Hong Kong 18
Brno 17
Roebling 17
Menlo Park 16
Redwood City 15
Nanjing 13
Seoul 13
Arosio 12
Naples 11
Guangzhou 9
Tokyo 9
Center 8
Colorado Springs 8
Falls Church 8
Helsinki 8
Inverigo 8
Hefei 7
Kunming 7
Mountain View 7
Nanchang 7
San Francisco 7
San Jose 7
Shanghai 7
São Paulo 7
Toronto 7
Detroit 6
Hangzhou 6
Bari 5
Bologna 5
Catania 5
Frankfurt am Main 5
Hounslow 5
Lappeenranta 5
Redmond 5
Turin 5
Verona 5
Atlanta 4
Chongqing 4
Jinan 4
Mülheim 4
New Bedfont 4
Palermo 4
Paris 4
Phoenix 4
Pune 4
Riyadh 4
Warsaw 4
Bogotá 3
Chennai 3
Chicago 3
Fuzhou 3
Hanover 3
Hebei 3
Islamabad 3
Kuala Lumpur 3
Roseau 3
Salo 3
Târgu Mureş 3
University Park 3
Abuja 2
Acton 2
Alessandria 2
Amsterdam 2
Ancona 2
Athens 2
Boardman 2
Brooklyn 2
Cagliari 2
Chengdu 2
Totale 13.674
Salva come PNG Salva come JPEG
Nome #
Neurophysiology of synaptic functioning in multiple sclerosis 513
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 477
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 464
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 454
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 453
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 450
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 438
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 436
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 417
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 414
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 410
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 408
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis 403
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 401
Epstein-Barr virus genetic variants are associated with multiple sclerosis 397
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 389
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 386
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study 380
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 369
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 362
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis 360
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 353
Reversible hyporegenerative anemia during natalizumab treatment 343
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 336
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 324
Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multi-centre, real world, quasi-randomized study 321
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 301
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 296
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 290
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 280
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 277
TRPV1 channels regulate cortical excitability in humans 263
Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis 262
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 243
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 236
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 218
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 155
Prototypical proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 145
Multiple Sclerosis: kFLC index values related to gender 136
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 131
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 128
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 94
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 88
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 86
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 86
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 83
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 71
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 70
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 68
A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset 66
Interleukin-1β alters hebbian synaptic plasticity in multiple sclerosis 65
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 63
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 60
Age at disease onset associates with oxidative stress, neuroinflammation, and impaired synaptic plasticity in relapsing-remitting multiple sclerosis 54
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential 54
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 51
A single nucleotide ADA genetic variant is associated to central inflammation and clinical presentation in MS: implications for cladribine treatment 50
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 50
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab 50
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 47
A large family with p.Arg554His mutation in ABCD1: clinical features and genotype/phenotype correlation in female carriers 47
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 45
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 45
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 45
Decipher non-canonical SPAST splicing mutations with the help of functional assays in patients affected by spastic paraplegia 4 (SPG4) 41
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 41
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 35
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 32
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 32
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression 30
Osteopontin Is Associated with Multiple Sclerosis Relapses 30
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 28
Physical exercise and synaptic protection in human and pre-clinical models of multiple sclerosis 26
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 26
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 26
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 25
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 24
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 24
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 21
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 16
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 13
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 11
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 9
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 6
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients 4
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 1
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types 1
Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation study 1
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 1
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity 1
Totale 15.762
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.746 0 0 0 0 315 431 397 354 385 324 268 272
2020/20212.732 258 294 257 303 319 286 466 299 74 71 75 30
2021/2022717 36 33 16 41 3 129 32 34 78 91 33 191
2022/20231.347 137 118 121 209 77 289 91 64 105 14 61 61
2023/2024541 86 20 24 29 39 123 28 40 25 26 21 80
2024/2025855 88 436 170 97 64 0 0 0 0 0 0 0
Totale 15.762